Fibrillin 2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-42353
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Immunogen sequence: Thr1550-Cys1791 (Uniprot#: P35556)
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for Fibrillin 2 Antibody
Immunohistochemistry-Paraffin: Fibrillin 2 Antibody [NBP3-42353] -
Immunohistochemistry-Paraffin: Fibrillin 2 Antibody [NBP3-42353] - DAB staining on IHC-P; Samples: Human Breast cancer Tissue
Immunohistochemistry-Paraffin: Fibrillin 2 Antibody [NBP3-42353] -
Immunohistochemistry-Paraffin: Fibrillin 2 Antibody [NBP3-42353] - DAB staining on IHC-P; Samples: Human Breast cancer Tissue; Primary Ab: 20ug/ml NBP3-42353
Western Blot: Fibrillin 2 Antibody [NBP3-42353] -
Western Blot: Fibrillin 2 Antibody [NBP3-42353] - Sample: Recombinant protein.Applications for Fibrillin 2 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
5-20ug/mL
Immunohistochemistry
5-20ug/mL
Western Blot
0.01-2ug/mL
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
PBS, pH7.4, 50% glycerol
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Fibrillin 2
Alternate Names
CCA, congenital contractural arachnodactyly, DA9, fibrillin 2, fibrillin 5, fibrillin-2
Gene Symbol
FBN2
Additional Fibrillin 2 Products
Product Documents for Fibrillin 2 Antibody
Product Specific Notices for Fibrillin 2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...